Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jul 30, 2010

Premium

Arrayit announced this week that it has hired Duane Steele to identify potential partnerships for the commercialization of its OvaDx test for ovarian cancer.

Steele was previously vice president of business development at IVAX Diagnostics and COO of Diamedix, IVAX's wholly owned in vitro diagnostics subsidiary.


Gregory Freitag was elected this week to Pressure BioSciences' board of directors, filling a newly created Class III position.

Freitag is CEO, CFO, and a director of LecTec, an intellectual licensing and holding company, as well as CEO of self-insurance service provider EmployRX. Previously he worked in business development at Pfizer Health Solutions and Guidant and co-founded HTS Biosystems, where he was CEO. His term on the board of directors will expire at Pressure Biosciences' 2011 shareholder meeting.


Wolfgang Renz joined PharmaNet Development Group this week as senior vice president of clinical operations. He will be based in the company's Zurich office where he will oversee its European clinical operations as well as its regional monitoring group in North America.

Previously Renz was general manager of JSS Medical Research, president of Samaritan Therapeutics, and adjunct professor of surgery at Montreal's McGill University.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.